Gradient Investments’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25
| Closed | -$1.35K | – | 510 |
|
|
2024
Q2 | $1.35K | Hold |
25
| – | – | ﹤0.01% | 1038 |
|
|
2024
Q1 | $1.7K | Hold |
25
| – | – | ﹤0.01% | 847 |
|
|
2023
Q4 | $1.57K | Hold |
25
| – | – | ﹤0.01% | 1302 |
|
|
2023
Q3 | $1.14K | Hold |
25
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q2 | $1.4K | Hold |
25
| – | – | ﹤0.01% | 1263 |
|
|
2023
Q1 | $1.13K | Hold |
25
| – | – | ﹤0.01% | 1189 |
|
|
2022
Q4 | $1.02K | Hold |
25
| – | – | ﹤0.01% | 1194 |
|
|
2022
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 1126 |
|
|
2022
Q2 | $2K | Sell |
25
-38
| -60% | -$3.04K | ﹤0.01% | 1034 |
|
|
2022
Q1 | $4K | Buy |
63
+25
| +66% | +$1.59K | ﹤0.01% | 917 |
|
|
2021
Q4 | $3K | Hold |
38
| – | – | ﹤0.01% | 1005 |
|
|
2021
Q3 | $4K | Hold |
38
| – | – | ﹤0.01% | 908 |
|
|
2021
Q2 | $6K | Hold |
38
| – | – | ﹤0.01% | 843 |
|
|
2021
Q1 | $5K | Hold |
38
| – | – | ﹤0.01% | 876 |
|
|
2020
Q4 | $3K | Hold |
38
| – | – | ﹤0.01% | 878 |
|
|
2020
Q3 | $3K | Hold |
38
| – | – | ﹤0.01% | 884 |
|
|
2020
Q2 | $3K | Sell |
38
-9
| -19% | -$711 | ﹤0.01% | 821 |
|
|
2020
Q1 | $2K | Buy |
+47
| New | +$2K | ﹤0.01% | 900 |
|